US · Healthcare · Healthcare Plans
EPS came in at 0.07 against a street estimate of 0.07 — a beat of 0.0%.
Analysts rate Clover Health Investments Corp a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $4.58.
| Fund | Stake |
|---|---|
| BlackRock Inc | 6.05% |
| Vanguard Capital Management, LLC | 3.22% |
| Geode Capital Management, LLC | 1.91% |
| State Street Corp | 1.82% |
| Charles Schwab Investment Management Inc | 1.01% |
| PNC Financial Services Group Inc | 0.71% |
| Vanguard Portfolio Management, LLC | 0.70% |
| Dimensional Fund Advisors, Inc. | 0.65% |
| Document | Date |
|---|---|
| Company announcement · Q3 2026 | 2026-07-17 |
| Company announcement · Q2 2026 | 2026-06-18 |
| Board / officer change · Q2 2026 | 2026-06-16 |
| Shareholder vote results · Q2 2026 | 2026-06-12 |
| Quarterly report · Q1 2026 | 2026-05-08 |
| Proxy statement · Q2 2026 | 2026-04-28 |
| Annual report FY2025 | 2026-02-27 |
| Quarterly report · Q3 2025 | 2025-11-07 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Clover Health Investments Corp — free to start.
Google PlayApp StoreData updated 2026-08-05.